Synthesis, characterization and cytotoxicity of some triarylbismuth(V) di(N-p-toluenesulfonyl) aminoacetates and the crystal structure of (4-CH 3C6H4SO2NHCH2CO 2)2Bi(C6H4Cl-4)3

Applied Organometallic Chemistry

Volumn 18, Issue 4, 2004, Pages 187-190

  Yu, Lin ^a   Ma, Yong Qiang ^a   Wang, Guo Cang ^a   Song, Hai Bin ^a   Wang, Hong Geng ^a   Li, Jin Shan ^a   Cui, Jing Rong ^b   Wang, Rui Qing ^b  

^a NANKAI UNIVERSITY   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Antitumor activity; Arylbismuth; Crystal structure

Indexed keywords

BISMUTH DERIVATIVE; BISMUTH DI(N 4 TOLUENESULFONYL) AMINOACETATE DERIVATIVE; GLYCINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG CYTOTOXICITY; DRUG SYNTHESIS; GEOMETRY; HUMAN; HUMAN CELL; INFRARED SPECTROMETRY; MASS SPECTROMETRY; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION;

EID: 1842576876     PISSN: 02682605     EISSN: None     Source Type: Journal    
DOI: 10.1002/aoc.609     Document Type: Article

References (29)

1. Suzuki H, Matano Y. Organobismuth Chemistry. Elsevier: 2001.
2. Supniewski JV, Adams R. J. Am. Chem. Soc. 1926; 48: 507.
3. Goel RG, Prasad HS. Can. J. Chem. 1970; 48: 2488.
4. Gilman H, Yale HL. J. Am. Chem. Soc. 1951; 73: 4470.
5. Ferguson G, Kaitner B, Glidewell C, Smith S. J. Organometal. Chem. 1991; 419: 283.
6. Suzuki H, Ikegami T, Matano Y, Azuma N. J. Chem. Soc. Perkin Trans. 1 1993; 2411.
7. Arnauld T, Barton DHR, Doris E. Tetrahedron 1997; 53: 4137.
8. Yu L, Ma YQ, Wang GC, Li JS, Du GH, Hu JJ. J. Organometal. Chem. 2003; 679: 173.
9. Silvestru C, Breunig HJ, Althaus H. Chem. Rev. 1999; 99: 3277.
10. Maeda S. In The Chemistry of Organic Arsenic, Antimony and Bismuth Compounds, Patai S (ed.). Wiley: New York, 1994; 725-759.
11. Reglinski J. In Chemistry of Arsenic, Antimony and Bismuth, Norman NC (ed.). Blackie Academic and Professional: London, 1997; 403-440.
12. Sadler PJ, Li H, Sun H. Coord. Chem. Rev. 1999; 185-186: 689.
13. Tiekink ERT. Oncology/Hematology. 2002; 42: 217.
14. Howden CW. Am. J. Med. 1996; 100: S27.
15. Hunt RH, Lam SK. J. Gastroenterol. Hepatol. 1998; 13: 21.
16. Tytgat GNJ. Digest. Dis. 1998; 16: 192.
17. Axon A. Eur. J. Gastroenterol. Hepatol. 1999; 11: S3.
18. Coyle WJ, Sedlack RE, Nemec R, Peterson R, Duntemann T, Murphy M, Lawson JM. Am. J. Gastroenterol. 1999; 94: 2885.
19. Steinbach G, Ford R, Glober G, Sample D, Hagemeister FB, Lynch PM, McLaughlin PW, Rodriguez MA, Romaguera JE, Sarris AH, Younes A, Luthra R, Manning JT, Johnson CM, Lahoti S, Shen Y, Lee JE, Winn RJ, Genta RM, Graham DY, Cabanillas FF. Ann. Intern. Med. 1999; 131: 88.
20. Jensen KA, Buchardt O. Acta Chem. Scand. 1961; 15: 447.
21. Barton DHR, Bhatnagar NY, Blazejewshi JC, Charpiot B, Finet JP, Lester DJ, Motherwell WB, Papoula MTB, Stanforth SP. J. Chem. Soc. Perkin. Trans. 1 1985; 2657.
22. Sheldrick GM. Acta Crystallogr. Sect. A 1990; 46: 467.
23. Sheldrick GM. SHELXL-97, program for crystal structure refinement. Universität Göttingen, Germany, 1997.
24. Mosmann T. J. Immunol. Methods 1983; 65: 55.
25. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd M. J. Natl. Cancer Inst. 1990; 24: 1107.
26. Whiffen DH. J. Am. Chem. Soc. 1956; 1350.
27. Brown DH, Mohammed A, Sharp DW. Spectrochim. Acta 1965; 21: 663.
28. Shobatake K, Postmus C, Ferraro JR, Nakamoto K. Appl. Spectrosc. 1969; 23: 12.
29. Clark RJH, Flint CD, Hempleman AJ. Spectrochim. Acta Part A 1987; 43: 805.